vs
Side-by-side financial comparison of Liberty Energy Inc. (LBRT) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Liberty Energy Inc. is the larger business by last-quarter revenue ($1.0B vs $622.0M, roughly 1.6× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 2.2%, a 32.2% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs 4.5%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -6.2%).
Liberty Energy Inc. is a North American energy services provider specializing in hydraulic fracturing and well completion solutions for oil and gas operators. It serves clients across major U.S. shale basins, offering low-emission equipment and tailored support to optimize well productivity.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
LBRT vs RPRX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $622.0M |
| Net Profit | $22.6M | $214.2M |
| Gross Margin | — | — |
| Operating Margin | 2.2% | 62.4% |
| Net Margin | 2.2% | 34.4% |
| Revenue YoY | 4.5% | 4.8% |
| Net Profit YoY | — | 2.9% |
| EPS (diluted) | $0.14 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $622.0M | ||
| Q3 25 | $947.4M | $609.3M | ||
| Q2 25 | $1.0B | $578.7M | ||
| Q1 25 | $977.5M | $568.2M | ||
| Q4 24 | $943.6M | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.2B | $537.3M |
| Q1 26 | $22.6M | — | ||
| Q4 25 | $13.7M | $214.2M | ||
| Q3 25 | $43.1M | $288.2M | ||
| Q2 25 | $71.0M | $30.2M | ||
| Q1 25 | $20.1M | $238.3M | ||
| Q4 24 | $51.9M | $208.2M | ||
| Q3 24 | $73.8M | $544.0M | ||
| Q2 24 | $108.4M | $102.0M |
| Q1 26 | — | — | ||
| Q4 25 | 20.6% | — | ||
| Q3 25 | 18.7% | — | ||
| Q2 25 | 22.1% | — | ||
| Q1 25 | 22.1% | — | ||
| Q4 24 | 21.4% | — | ||
| Q3 24 | 26.2% | — | ||
| Q2 24 | 27.9% | — |
| Q1 26 | 2.2% | — | ||
| Q4 25 | 1.9% | 62.4% | ||
| Q3 25 | -0.3% | 70.1% | ||
| Q2 25 | 3.6% | 36.3% | ||
| Q1 25 | 1.9% | 94.0% | ||
| Q4 24 | 2.6% | 60.9% | ||
| Q3 24 | 9.4% | — | ||
| Q2 24 | 12.2% | 50.2% |
| Q1 26 | 2.2% | — | ||
| Q4 25 | 1.3% | 34.4% | ||
| Q3 25 | 4.5% | 47.3% | ||
| Q2 25 | 6.8% | 5.2% | ||
| Q1 25 | 2.1% | 41.9% | ||
| Q4 24 | 5.5% | 35.1% | ||
| Q3 24 | 6.5% | 96.3% | ||
| Q2 24 | 9.3% | 19.0% |
| Q1 26 | $0.14 | — | ||
| Q4 25 | $0.08 | $0.49 | ||
| Q3 25 | $0.26 | $0.67 | ||
| Q2 25 | $0.43 | $0.07 | ||
| Q1 25 | $0.12 | $0.55 | ||
| Q4 24 | $0.31 | $0.46 | ||
| Q3 24 | $0.44 | $1.21 | ||
| Q2 24 | $0.64 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $699.1M | $618.7M |
| Total DebtLower is stronger | $7.1M | $9.0B |
| Stockholders' EquityBook value | $1.9B | $9.7B |
| Total Assets | $4.4B | $19.6B |
| Debt / EquityLower = less leverage | 0.00× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $699.1M | — | ||
| Q4 25 | $27.6M | $618.7M | ||
| Q3 25 | $13.5M | $938.9M | ||
| Q2 25 | $19.6M | $631.9M | ||
| Q1 25 | $24.1M | $1.1B | ||
| Q4 24 | $20.0M | $929.0M | ||
| Q3 24 | $23.0M | $950.1M | ||
| Q2 24 | $30.0M | $1.8B |
| Q1 26 | $7.1M | — | ||
| Q4 25 | $246.6M | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $190.5M | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
| Q1 26 | $1.9B | — | ||
| Q4 25 | $2.1B | $9.7B | ||
| Q3 25 | $2.1B | $9.6B | ||
| Q2 25 | $2.0B | $9.5B | ||
| Q1 25 | $2.0B | $9.8B | ||
| Q4 24 | $2.0B | $10.3B | ||
| Q3 24 | $2.0B | $10.3B | ||
| Q2 24 | $1.9B | $9.8B |
| Q1 26 | $4.4B | — | ||
| Q4 25 | $3.6B | $19.6B | ||
| Q3 25 | $3.5B | $19.3B | ||
| Q2 25 | $3.4B | $18.3B | ||
| Q1 25 | $3.4B | $17.6B | ||
| Q4 24 | $3.3B | $18.2B | ||
| Q3 24 | $3.3B | $18.0B | ||
| Q2 24 | $3.2B | $17.7B |
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.12× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.10× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $827.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 13.1% | — |
| Cash ConversionOCF / Net Profit | — | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $195.4M | $827.1M | ||
| Q3 25 | $51.5M | $702.6M | ||
| Q2 25 | $170.6M | $364.0M | ||
| Q1 25 | $192.1M | $596.1M | ||
| Q4 24 | $177.3M | $742.5M | ||
| Q3 24 | $244.5M | $703.6M | ||
| Q2 24 | $248.2M | $658.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-10.0M | — | ||
| Q3 25 | $-67.2M | — | ||
| Q2 25 | $33.1M | — | ||
| Q1 25 | $58.2M | — | ||
| Q4 24 | $-26.2M | — | ||
| Q3 24 | $77.9M | — | ||
| Q2 24 | $112.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | -1.0% | — | ||
| Q3 25 | -7.1% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 6.0% | — | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 9.7% | — |
| Q1 26 | 13.1% | — | ||
| Q4 25 | 19.8% | — | ||
| Q3 25 | 12.5% | — | ||
| Q2 25 | 13.2% | — | ||
| Q1 25 | 13.7% | — | ||
| Q4 24 | 21.6% | — | ||
| Q3 24 | 14.6% | — | ||
| Q2 24 | 11.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 14.28× | 3.86× | ||
| Q3 25 | 1.20× | 2.44× | ||
| Q2 25 | 2.40× | 12.06× | ||
| Q1 25 | 9.55× | 2.50× | ||
| Q4 24 | 3.42× | 3.57× | ||
| Q3 24 | 3.31× | 1.29× | ||
| Q2 24 | 2.29× | 6.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LBRT
Segment breakdown not available.
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
